Recursion Pharmaceuticals appointed former FDA principal deputy commissioner Namandjé Bumpus, PhD, and Elaine Sun, the COO and CFO of Mammoth Biosciences, to its board of directors. CAMP4 Therapeutics ...

Merck (MRK) ended the recent trading session at $94.02, demonstrating a -0.74% swing from the preceding day's closing price. The stock's change was less than the S&P 500's daily gain of 1.08%.

We came across a bullish thesis on Merck & Co., Inc. (MRK) on Substack by Jimmy Investor. In this article, we will summarize ...

According to the company, the new, 225,000-square-foot expansion is a "crucial component" of a more than $12 billion infusion ...

Merck said on Tuesday it has opened a $1-billion ... Trump has been piling pressure on drugmakers since taking office to move medicine production to the U.S., and has threatened to impose ...

Imagine yourself as a passive income investor looking for a medical stock with significant share growth potential. Wall ...

Merck Data at ACC.25 Highlight Innovative Advancements and Commitment to Improving Outcomes for People Living with Cardiovascular Disease ...

Merck's newly developed injected version of its blockbuster cancer drug, Keytruda, may be at the center of a potential patent ...

The Merck Foundation, partnered with African First Ladies, is enhancing women's empowerment in underserved communities.

March 11 (Reuters) - Merck (MRK.N), opens new tab said on Tuesday ... Trump has been piling pressure on drugmakers since taking office to move medicine production to the U.S., and has threatened ...